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Abstract: The therapeutic effect of polysaccharide of large yellow croaker swim bladder 
(PLYCSB) on lupus nephritis has been studied in vivo. A high concentration (50 mg/kg 
dose) of PLYCSB reduced the levels of serum inflammatory cytokine levels of IL-6, IL-12, 
TNF-α and IFN-γ compared to a low concentration (25 mg/kg dose) and control mice. SCr, 
BUN, TC and TG serum levels of PLYCSB treated mice were lower than those of control 
mice, and TP and ALB serum levels were higher than control mice. Control mice tested  
ds-DNA positive at the 6th week, and 50 mg/kg treated mice tested at the 10th week after 
the experiment began. The output of urine protein of 50 mg/kg PLYCSB treated mice was 
most closely comparable to the normal mice. The glomerular number of 50 mg/kg 
PLYCSB treated mice was more than the 25 mg/kg dose and control groups, and the   
50 mg/kg dose group showed the lowest glomerular sclerosis index in lupus nephritis mice. 
By RT-PCR and western blot assay, PLYCSB significantly induced inflammation in 
kidney tissues of mice by downregulating NF-κB-p65, TGF-β1, Fas, FasL and 
upregulating IκB-α. These results suggest that PLYCSB showed a potential curative effect 
on lupus nephritis as a drug or functional food. 
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1. Introduction 
As one of the main commercial fishes in the coastal waters of China, the large yellow croaker 
(Larimichthys crocea) swim bladder (LYCSB) contains many nutrients, such as numerous proteins, 
microelements and vitamins. Traditional medicine advocates that it has a good curative effect on 
diseases including amnesia, insomnia, dizzy, anepithymia and weakness after delivery [1]. Researchers 
also suggested that LYCSB served to remove free radicals and ward against inflammation and   
cancer [2]. LYCSB is an important balancing organ and the amount of polysaccharide in it is as much 
as 10% of its weight. Polysaccharide is a kind of important functional material. It hass been proven 
that polysaccharide in swimming bladders can rapidly heal cuts and prevent infection as well as 
thrombotic events [3]. In vivo experiments have proved that polysaccharide in lentinus edodes and 
spirulina seaweed serves to prevent and cure injuries [4,5]. 
Lupus nephritis (LN) is systemic lupus erythematosus (SLE). It is a kind of immune complex 
nephritis caused by exhausting the kidney. Its clinical features include all features of 
glomerulonephritis [6]. The murine lupus nephritis model is an internationally recognized and widely 
applied animal model. The experimental conditions are easy to control. Renal pathological lesions 
appear after the induction. The lesion is similar to SLE occuring in human beings. The main   
features include lymphonodular hyperplasia, the formation of autoantibodies, and infection with 
glomerulonephritis [7]. Renal morphologic changes include the segmental or pervasive proliferation of 
glomerular mesangial, membraneous nephritis and glomerular sclerosis, which is likely to happen in 
patients with more serious cases [8]. 
In the present study, the preventative effect on lupus nephritis of polysaccharide of large yellow 
croaker swim bladder (PLYCSB) was determined. The serum levels and inflammation-related 
cytokines levels were used to determine the therapeutic effect of PLYCSB on lupus nephritis mice. 
The status of glomerular tissues was checked by histology. The mRNA and protein gene expressions 
by the tissues were also assessed to try to understand the basis for the therapeutic effect. 
2. Materials and Methods 
2.1. Polysaccharide of Large Yellow Croaker Swim Bladder (PLYCSB) Preparation 
Wild Yellow Sea large yellow croaker was purchased from Shandong Province in China. Swim 
bladder of large yellow croaker (1 kg) was dried by freeze-drying, and the dried samples were crushed. 
3 L petroleum ether was added into swimming bladder of large yellow croaker and then reflux 
extraction was done twice (1 h each time) at 60 °C to remove the protein, and the residuals were 
gathered after filtration. After this, 3 L ethyl alcohol was added and reflux extraction were performed 
for 3 h, the residuals without protein were filtered and gathered. Finally, 3 L water was added and the 
residuals were extracted at 60 °C for 2 h, and the filter liquor was collected. The crude polysaccharide 
of large yellow croaker swim bladder was collected after evaporating [9]. Nutrients 2014, 6  1225 
 
 
2.2. Lupus Nephritis Experiment 
Eight-week-old male DBA/2 mice (n = 20) and female B6D2F1 (C57BL/6J × DBA/2) hybrid mice 
(n = 40) were purchased from the Experimental Animal Center of Third Military Medical University 
(Chongqing, China). They were maintained in a temperature-controlled facility (temperature 23 ± 1 °C, 
relative humidity 50 ± 5%) with a 12-h light/dark cycle. The mice had unlimited access to a standard 
mouse chow diet and water. The spleen, thymus and lymphonodus of DBA/2 mice were isolated in a 
germ-free state. Then, they were grinded and cut into pieces in normal saline. Cells were isolated using 
lymphocyte isolation medium. A single-cell suspension was made with D-Hanks solution. The ratio of 
spleen, thymus and lymphonodus was 3:2:1. The cell suspension was blended with 2.5 × 10
8 cells/mL 
of living cells on day 0, the 3rd day, the 7th day, the 10th day respectively to B6D2F1 mice in the 
control group and the PLYCSB treated groups. 0.2 mL of cell suspension was injected into the body of 
B6D2F1 (C57BL/6J × DBA/2) hybrid mice by means of tail vein injection, and then D-Hanks solution 
was injected into mice in the normal group. The control and normal groups B6D2F1 mice received no 
PLYCSB treatment. After the single-cell suspension was injected at the first day, the PLYCSB groups 
B6D2F1 mice were received by oral administration of 25 or 50 mg/kg PLYCSB everyday for   
12 weeks. These experiments followed a protocol approved by the Animal Ethics Committee of 
Chongqing Medical University (Chongqing, China) [10]. 
2.3. Analysis of Inflammation-Related Cytokines in Serum by Enzyme-Linked Immunosorbent  
Assay (ELISA) 
For the serum cytokine assay, blood from the inferior vena cava was collected in a tube and 
centrifuged at 730× g, 4 °C for 10 min. The serum was aspirated and assayed as described below. 
Concentrations of inflammatory-related cytokines IL-6, IL-12, TNF-α and IFN-γ in serum were 
measured by ELISA according to the manufacturer’s instructions (Biolegend, San Diego, CA, USA). 
Briefly, biotinylated antibody reagent was added to 96-well plates, then supernatants of homogenized 
serum were added and the plates were incubated at 37 °C in CO2 for 2 h. After washing with PBS, 
streptavidin-horseradish peroxidase (HRP) solution was added and the plate was incubated for 30 min 
at room temperature. The absorbance was measured at 450 nm using a microplate reader (iMark;  
Bio-Rad, Hercules, CA, USA) [11]. 
2.4. Serum Levels of SCr (Serum Creatinine), BUN (Blood Urea Nitrogen), TC (Total Cholesterol),  
TG (Triglyceride), TP (Total protein) and ALB (Albumin) Determination 
Blood was drawn from eye orbit with glass capillary syringe to prepare blood serum every   
two weeks since the injection of lymphocyte for the first time. The mice blood was collected in a tube 
and centrifuged at 730× g, 4 °C for 10 min. Then the SCr, BUN, TC (total cholesterol), TG, TP and  
ALB levels of the serum were determined using commercially available kits (Unison Biotech Inc., 
Hsinchu, Taiwan). Nutrients 2014, 6  1226 
 
 
2.5. Auto-Antibody ds-DNA Assay 
Blood was drawn from eye orbit with a glass capillary syringe to prepare blood serum every   
two weeks since the first injection of lymphocytes. The auto-antibody ds-DNA was determined with 
titer plate technology and indirect immunofluorescence and was observed with a fluorescence 
microscope (BX50, Olympus, Tokyo, Japan). 
2.6. Urinary Protein Excretion Test 
Since the first injection of lymphocytes, mice of different groups were fed in metabolism cages 
every two weeks before the experiment. They drank and ate freely in cages. Their urine between  
8:00 am and 8:00 am in the next day was then collected. The output of urine protein during 24 h was 
determined by means of Coomassie Brilliant Blue [11]. 
2.7. Histology Assay 
Renal tissue specimens were fixed with 10% neutral Formalin. Following Paraffin embedding,   
3 μm sections were then stained with HE. The total number of cell nuclei in the cross section of 
glomerulus was counted. The hardening exponent of the glomerulus was determined by a   
semi-quantitative scoring method. 25 glomeruli of each animal were counted and were averaged [11]. 
2.8. Reverse Transcription-Polymerase Chain reaction (RT-PCR) of Inflammation—Related Gene 
Expression in the Kidney Tissue 
Total RNA from kidney tissue was isolated using Trizol reagent (Invitrogen, Carlsbad, CA, USA) 
according to the manufacturer’s recommendations. The RNA was digested with RNase-free DNase 
(Roche, Basel, Switzerland) for 15min at 37 °C and purified using a RNeasy kit (Qiagen, Hilden, 
Germany) according to the manufacturer’s protocol. cDNA was synthesized from 2 μg of total RNA 
by incubation at 37 °C for l h with avian myeloblastosis virus reverse transcriptase (GE Healthcare, 
Little Chalfont, UK) with random hexanucleotides according to the manufacturer’s instruction. The 
primers used to specifically amplify the genes of interest were: NF-κB-p65 forward: 5′-CAC TTA 
TGG ACA ACT ATG AGG TCT CTG G-3′ and reverse: 5′-CTG TCT TGT GGA CAA CGC AGT 
GGA ATT TTA GG-3′; IκB-α forward: 5′-GCT GAA GAA GGA GCG GCT ACT-3′ and reverse:  
5′-TCG TAC TCC TCG TCT TTC ATG GA-3′; TGF-β1 forward: 5′-CTT CAG CTC CAC AGA GAA 
GAA CGT C-3′ and reverse: 5′-CAC GAT CAT GTT GGA CAA CTG CTC-3′; Fas forward: 5′-GAA 
ATG AAA TCC AAA GCT-3′ and reverse: 5′-TAA TTT AGA GGC AAA GTG GC-3′; FasL forward: 
5′-GGA TTG GGC CTG GGG ATG TTT CA-3′ and reverse: 5′-TTG TGG CTC AGG GGC AGG 
TTG TTG-3′. The internal control gene of GAPDH was amplified using the primers: forward:   
5′-CGG AGT CAA CGG ATT TGG TC-3′ and reverse: 5′-AGC CTT CTC CAT GGT CGT GA-3′. 
Amplification was performed in a thermal cycler (Eppendorf, Hamburg, Germany). The polymerase 
chain reaction (PCR) products were separated in 1.0% agarose gels and visualized with ethidium 
bromide staining [12]. Nutrients 2014, 6  1227 
 
 
2.9. Protein Extraction and Western Blot Analysis in the Kidney Tissue 
Total kidney tissue protein was obtained with RIPA buffer as previously described. Protein 
concentrations were determined with a Bio-Rad protein assay kit (Hercules, CA, USA). For the 
western blot analysis, aliquots of the lysate containing 30–50 μg protein were separated by sodium 
dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and then electrotransferred onto a 
nitrocellulose membrane (Schleicher and Schuell, Keene, NH, USA). The membranes were subjected 
to immunoblot analysis and the proteins were visualized by an enhanced chemiluminescence (ECL) 
method (GE Healthcare, Buckinghamshire, UK). The cell lysates were separated by 12% SDS-PAGE, 
transferred onto a polyvinylidene fluoride membrane (GE Healthcare, Buckinghamshire, UK), blocked 
with 5% skimmed milk and hybridized with primary antibodies (diluted 1:1000). The antibodies 
against NF-κB-p65, IκB-α, TGF-β1, Fas and FasL were obtained from Santa Cruz Biotechnology Inc. 
(Santa Cruz, CA, USA). The blots were then incubated with the horseradish peroxidase—conjugated 
secondary antibody (Santa Cruz Biotechnology Inc., Santa Cruz, CA, USA) for 1 h at room 
temperature. The blots were washed three times with PBS-T and then developed by enhanced 
chemiluminescence (Amersham Life Science, Arlington Heights, IL, USA) [12]. 
2.10. Statistical Analysis 
Data are presented as the mean ± SD. Differences between the mean values for individual groups 
were assessed with a one-way ANOVA with Duncan’s multiple range test. Differences were 
considered significant when p < 0.05. SAS version 9.1 (SAS Institute Inc., Cary, NC, USA, 2009) was 
used for statistical analyses [12]. 
3. Results 
3.1. Cytokine IL-6, IL-12, TNF-α and IFN-γ Levels 
The normal mice showed the lowest IL-6, IL-12, TNF-α and IFN-γ levels; however, these levels of 
control mice were more than three times of normal mice (p < 0.05, Table 1). The levels of IL-6, IL-12, 
TNF-α and IFN-γ in 25 and 50 mg/kg PLYCSB treated mice were lower than control mice. And the  
50 mg/kg PLYCSB treated mice had lower levels of IL-6, IL-12, TNF-α and IFN-γ than 25 mg/kg 
PLYCSB treated mice. 
Table 1. Serum IL-6, IL-12, TNF-α and IFN-γ levels of lupus nephritis mice treated with 
polysaccharide of large yellow croaker swim bladder (PLYCSB). 
Group  IL-6 (pg/mL)  IL-12 (pg/mL)  TNF-α (pg/mL)  IFN-γ (pg/mL) 
Normal  51.34 ± 3.63 
a  432.65 ± 41.26 
A  110.36 ± 6.68 
a  41.27 ± 2.98 
A 
Control  308.95 ± 31.23 
b  1711.56 ± 89.91 
B 731.83 ± 13.60 
b  127.28 ± 8.13 
B 
PLYCSB        
25 mg/kg  201.46 ± 22.37 
c  1227.10 ± 77.21 
C 537.83 ± 19.55 
c  81.43 ± 5.44 
C 
50 mg/kg  131.61 ± 20.43 
d  871.74 ± 32.36 
D  301.18 ± 14.76 
d  63.65 ± 6.35 
D 
a–d, A–D Mean values with different letters in the same column are significantly different (p < 0.05) according 
to Duncan’s multiple range test. Nutrients 2014, 6  1228 
 
 
3.2. Serum SCr, BUN, TC, TG, TP and ALB Levels 
The SCr, BUN, TC and TG serum levels in control mice were higher than in the other groups mice 
and these levels in normal mice were significantly decreased (p < 0.05, Table 2). Mice treated with 
PLYCSB also had decreased levels of SCr, BUN, TC and TG levels compared to the control mice, but 
higher than in normal mice, PLYCSB at 50 mg/kg could bring levels of SCr, BUN, TC, and TG close 
to normal levels. TP and ALB serum levels in this experiment showed the reverse trends, the levels in 
each group from high to low were the normal group, 50 mg/kg treated group, 25 mg/kg treated group 
and control group. 
Table 2. Serum SCr, BUN, TC, TG, TP and ALB levels of lupus nephritis mice treated 
with polysaccharide of large yellow croaker swim bladder (PLYCSB). 
Group SCr  (μmol/L)  BUN (mmol/L) TC (mmol/L)
TG 
(mmol/L) 
TP (g/L)  ALB (g/L) 
Normal  61.21 ± 4.21 
a  1.44 ± 0.36 
A  1.71 ± 0.23 
d  0.97 ± 0.12 
A 52.27 ± 3.28 
b  35.18 ± 1.38 
B
Control  134.72 ± 17.88 
b  14.87 ± 2.12 
B  16.42 ± 2.17 
a 14.76 ± 1.28 
B 22.82 ± 1.65 
a  12.27 ± 0.22 
A
PLYCSB          
25 mg/kg  107.82 ± 2.86 
c  7.22 ± 1.18 
C  12.67 ± 2.97 
b 8.39 ± 1.26 
C 35.91 ± 1.88 
d  20.09 ± 0.98 
D
50 mg/kg  80.37 ± 2.77 
d  4.62 ± 0.87 
D  6.26 ± 0.67 
c  4.51 ± 1.19 
D 42.67 ± 1.20 
c  28.17 ± 0.68 
C
a–d, A–D Mean values with different letters in the same column are significantly different (p < 0.05) according 
to Duncan’s multiple range test. 
3.3. ds-DNA Positive Rate during the Experiment 
The autoantibody ds-DNA was measured by indirect immunofluorescence in the 2nd, 4th, 6th, 8th, 
10th and 12th week. The ds-DNA antibody titer of serum was observed with a fluorescence 
microscope. With the tilter being 1:20, the result shows that all mice of the control group tested 
positive since the sixth week and the LN induction to them all is successful. Mice from the   
low-concentration group tested positive at the 8th week and mice from the high-concentration group 
tested positive at the 10th week, which means that the samples slow down the speed that mice were 
infected with LN (Table 3). 
Table 3. ds-DNA positive rate of polysaccharide of large yellow croaker swim bladder 
(PLYCSB) treated lupus nephritis mice (n = 10, titer = 1:20). 
Group  2 Weeks  4 Weeks  6 Weeks  8 Weeks  10 Weeks  12 Weeks 
Normal 0/10 
a (0%)  0/10 
A (0%)  0/10 
d (0%)  0/10 
D (0%)  0/10 
c (0%)  0/10 
C (0%) 
Control 5/10 
b (50%)  8/10 
B (80%) 10/10 
b (100%) 10/10 
B (100%) 10/10 
b (100%)  10/10 
B (100%)
PLYCSB            
25 mg/kg  4/10 
c (40%)  6/10 
C (60%) 8/10 
c (80%)  10/10 
B (100%) 10/10 
b (100%)  10/10 
B (100%)
50 mg/kg  4/10 
c (40%)  5/10 
D (50%) 6/10 
a (60%)  7/10 
C (70%)  10/10 
b (100%)  10/10 
B (100%)
a–d, A–D Mean values with different letters in the same column are significantly different (p < 0.05) according 
to Duncan’s multiple range test. Nutrients 2014, 6  1229 
 
 
3.4. Change of Urine Protein during the Experiment  
The output of urine protein in normal mice showed no significant change during the experiment, but 
mice from the other groups displayed increased urine protein as time prolonged. The urine protein 
contents in lupus nephritis mice were higher than those in PLYCSB treated mice and normal mice 
(Table 4). The output of urine protein in mice treated with a high concentration (50 mg/kg dose) 
PLYCSB was closer to the normal mice. 
Table 4. Output of urine protein of polysaccharide of large yellow croaker swim bladder 
(PLYCSB) treated lupus nephritis mice (n = 10, mg/24 h). 
Group  2 Weeks  4 Weeks  6 Weeks  8 Weeks  10 Weeks  12 Weeks 
Normal  0.73 ± 0.09 
a 0.79 ± 0.11 
A 0.82 ± 0.06 
a 0.88 ± 0.10 
A 0.87 ± 0.11 
a  0.90 ± 0.04 
A
Control  5.75 ± 0.63 
b 6.22 ± 0.54 
B 7.87 ± 0.81 
b 8.24 ± 0.72 
B 8.88 ± 0.50 
b  9.12 ± 1.01 
B
PLYCSB          
25 mg/kg  3.26 ± 0.41 
c 4.03 ± 0.61 
C 4.50 ± 0.36 
c 5.11 ± 0.53 
C 6.05 ± 0.39 
c  6.39 ± 0.41 
C
50 mg/kg  2.02 ± 0.27 
d 2.35 ± 0.19 
D 2.72 ± 0.11 
d 3.12 ± 0.23 
D 3.41 ± 0.07 
d  4.89 ± 0.38 
D
a–d, A–D Mean values with different letters in the same column are significantly different (p < 0.05) according 
to Duncan’s multiple range test. 
3.5. Glomerular Number and Glomerular Sclerosis Index by Histological Analysis 
In the end of this experiment, through the H&E histological analysis, there were 35 ± 3 glomeruli in 
one kidney section for each normal mice, the glomerular number in control mice was much lower with 
13 ± 3. PLYCSB could help to reduce the glomerular change, and the 50 mg/kg dose PLYCSB showed 
a stronger effect (Table 5). Glomerular sclerosis index of control mice was highest in all groups, and 
the sclerosis indexes of PLYCSB-group mice were reduced depending on the concentration. 
Table 5. Glomerular number and glomerular sclerosis index of polysaccharide of large 
yellow croaker swim bladder (PLYCSB) treated lupus nephritis mice (n = 10, mg/24 h).  
Group  Number of Glomerular  Glomerular Sclerosis Index 
Normal  35 ± 3 
a  0.00 ± 0.00 
A 
Control  13 ± 3 
b  3.12 ± 0.96 
B 
PLYCSB    
25 mg/kg  22 ± 2 
c  2.03 ± 0.45 
C 
50 mg/kg  27 ± 3 
d  1.57 ± 0.32 
D 
a–d, A–D Mean values with different letters in the same column are significantly different (p < 0.05) according 
to Duncan’s multiple range test. 
3.6. Gene Expression of NF-κB-p65, IκB-α, TGF-β1, Fas and FasL 
RT-PCR and western blotting were used to determine whether the inflammatory actions of 
PLYCSB were associated with inhibition of NF-κB-p65, IκB-α, TGF‑β1, Fas and/or FasL gene 
expression. As shown in Figure 1, mRNA and protein expression of NF-κB-p65 and IκB-α were 
changed in mice treated with PLYCSB. mRNA and protein expression of NF-κB-p65 were 
significantly decreased while IκB-α mRNA and protein levels were increased (p < 0.05). PLYCSB Nutrients 2014, 6  1230 
 
 
significantly decreased mRNA and protein expression of TGF-β1, and the TGF-β1 level mice treated 
with the high concentration of 50 mg/kg PLYCSB lower than those treated with the 25 mg/kg dose 
(Figure 2). With the PLYCSB treatment, mRNA and protein expressions of Fas and FasL were 
gradually elevated (Figure 3). NF-κB-p65, TGF-β1, Fas and FasL gene expression of normal mice 
showed the lowest levels, control mice showed the highest levels, and the IκB-α of normal and control 
mice showed the opposite tendency. Overall, the results of this experiment showed that PLYCSB had a 
potent anti-inflammatory effect on lupus nephritis. 
Figure 1. Effects of large yellow croaker swim bladder (PLYCSB) on the mRNA and 
protein expression of NF-κB-p65 and IκB-α in lupus nephritis mice. Fold-ratio: gene 
expression/GAPDH (β-actin) × control numerical value (control fold ratio: 1). 
a–d Mean 
values with different letters over the bars are significantly different (p < 0.05) according to 
Duncan’s multiple range test. 
 
Figure 2. Effects of large yellow croaker swim bladder (PLYCSB) on the mRNA and 
protein expression of TGF-β1 in lupus nephritis mice. Fold-ratio: gene expression/GAPDH 
(β-actin) × control numerical value (control fold ratio: 1). 
a–d Mean values with different 
letters over the bars are significantly different (p < 0.05) according to Duncan’s multiple 
range test. 
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Figure 3. Effects of large yellow croaker swim bladder (PLYCSB) on the mRNA   
and protein expression of Fas and FasL in lupus nephritis mice.
  Fold-ratio: gene 
expression/GAPDH (β-actin) × control numerical value (control fold ratio: 1). 
a–d Mean values 
with different letters over the bars are significantly different (p < 0.05) according to 
Duncan’s multiple range test. 
 
4. Discussion 
Swim bladder has been historically used as a Chinese folk medicine. Base on previous scientific 
data, swim bladder has been recently reported to ameliorate different pathological conditions of 
inflammation, as well as effectively strengthening the function of platelets, capillary vessels and 
clotting factors [13]. Polysaccharide is the main constituent of swim bladder, but there were not many 
studies performed regarding the polysaccharide found in the swim bladder. In this study, the 
therapeutic effect on lupus nephritis of polysaccharide of large yellow croaker swim bladder was 
determined in mice, and the results demonstrated that the PLYCSB conferred a therapeutic effect of 
lupus nephritis in animal model experiments. 
Serum creatinine and urea nitrogen are nitrogenous organic compounds and the end products of 
protein metabolism. When renal function was normal, these small molecules are filtered from the 
glomerulus. When the kidney suffers from lesions, the filtering capability of the glomerulus decreased 
and the content of serum creatinine and urea nitrogen increased. This increase in serum levels could be 
used as an index for the clinical diagnosis of renal damage [14]. 
Too much cholesterol and triglycerides are the cause hyperlipemia. When nephropathy deteriorated 
to a certain degree, features of hyperkalemia would co-exist. Therefore, cholesterol and triglyceride 
could also be considered as an index to renal hypofunction and renal lesion [15]. 
Protein in urine was lost for a long time in nephrotic syndrome. The total protein in serum was 
drastically reduced [16]. Albumin is the most prevalent protein in serum. It serves to cure serious 
diseases including edema caused by clinically curative nephropathy. It was thus evident that keeping 
the amount of total protein and albumin in serum is an important way to maintain normal renal Nutrients 2014, 6  1232 
 
 
function. The decrease of the content of total protein and albumin are the manifestations of poor renal 
function [15]. 
The final stage of lupus nephritis is represented by Global sclerosis involving most of the glomeruli, 
and represents healing prior to inflammatory injury. The sclerosis aggravated glomeruli parenchymal 
cells reducing [17]. 
A high-concentration of antibody to ds-DNA seemed to be seen only in SLE. Therefore, this 
antibody to ds-DNA was specific to SLE. The antibody to ds-DNA was closely related to the disease 
activity index and especially to LN and could be used as an index to diagnose systematic lupus 
erythematosus [18]. 
NF-κB is an important transcription factor serving to convey signals in the cell. It’s reported that it 
is decisive in the gene transcription regulation of numerous factors in the aforementioned immune 
inflammation [19]. Nephridial tissue of normal mice appeared with a few mesangial cell and NF-κB, 
which indicates that moderate NF-κB activity might be necessary to adjust physiological function of 
normal mixed renal cells [20]. Guijarro et al. [21] found that activation of NF-κB in mesangial cell 
nurtured in vitro can enhance the reproduction of mesangial cell and serves to fulfill centering control 
function to multiple chemokines secreted by mesangial cells. According to Rangan et al. [22], when 
interstitial nephritis was accompanied by large amount of albuminuria, NF-κB in the renal cortex was 
activated and TNF-α, IL-6 and TGF-β increased. After treatment, the activation of NF-κB decreased 
and damage of renal interstitium decreased, and IL-6 and TGF-β expression reduced. By the 
expression quantity of TGF-β mRNA in kidneys of the BXSB mice assay, TGF-β played an important 
role in the pathological accumulation of extracellular matrix in lupus nephritis and the formation 
process of glomerular sclerosis [23]. Experimental results showed that TNF-α and IL-6 levels in serum 
of the PLYCSB treated groups decrease greatly compared with the LN control group, which came to 
the same result with that of Rangan. IL-12 plays an important role in LN autoimmune response,   
and the level of IL-12 in the active stage of LN rises. One of the features of LN was the emergence of 
large amounts of autoantibody. It was proven that IL-12 can promote cells to produce this 
autoantibody directly. The increase in the content of IL-12 led to the large amount of production of this 
autoantibody [24]. As an inflammatory mediator, IFN-γ takes part in the whole immune inflammatory 
process of nephritis. The level IFN-γ in glomerulonephritis is substantially increased [25]. After the 
occurrence of nephritis, cytokines related to inflammation change. The content of cytokines related to 
inflammation, like IL-6, IL-12, TNF-α and IFN-γ, in blood would also obviously increase [26]. 
PLYCSB serves to reduce the content of these cytokines in blood. Thereby, PLYCSB has an obvious 
curative effect to LN. In this research, the expression of NF-κB and TGF-β in mice in the LN control 
group is higher than that in mice of the normal group and the PLYCSB treated groups. The better the 
curative effect of PLYCSB, the weaker the expression of NF-κB and TGF-β. Meanwhile, IκB 
expression showed the opposite tendency. 
Fas and FasL are the molecules that cause the death of cells. Fas is a member of the ErbB of TNF 
nerve growth factors and exists in the surface of active T/B leukomonocytes and hematopoietic cells, 
as well as other tissues [27]. Fas induced the death of cells through oxidative stress after interacting 
with its natural ligand [28]. It was proven that the apoptosis rate of monocytes of LN patients is faster 
than that of normal people. FasL is a member of TNF family. In clinical checks, it was found that no Nutrients 2014, 6  1233 
 
 
FasL is obviously detected in the tissues of normal people while there is palpable FasL in LN patients. 
The increase of FasL level is likely to be caused by the change of LN [29]. 
5. Conclusions 
In summary, the lupus nephritis therapeutic effect of PLYCSB was evaluated by various in vivo 
experimental methods, including serum cytokine assays of IL-6, IL-12, TNF-α and IFN-γ; an assay for 
serum levels of SCr, BUN, TC, TG, TP and ALB; an auto-antibody ds-DNA assay, analysis of urinary 
protein excretion, a histology assay, tissue RT-PCR and western blot assays for checking the 
inflammatory related genes of NF-κB-p65, IκB-α, TGF‑β1, Fas and FasL. Analysis of the various 
mice treatment groups revealed that PLYCSB had a therapeutic effect on lupus nephritis, indicating 
that PLYCSB represents a potentially useful agent for the treatment or prevention of lupus nephritis  
in mice. 
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